A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

Clinical trial NCT05789069 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05789069
Sponsor: HiFiBiO Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma Melanoma Non Small Cell Lung Cancer Gastric Cancer Colorectal Cancer

Start date: 2023-05-09
Primary completion: 2026-12-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.